banner
  • Premium Coccidia Supplier from China – Custom Solutions & Factory Price

İyl . 22, 2025 12:01 Back to list

Premium Coccidia Supplier from China – Custom Solutions & Factory Price



Company: Shijiazhuang Huajun Animal Pharmaceutical Co., LTD
Website: https://www.zthjpharma.com
Email: kuayu@zthjpharma.com
Phone: +86-18931979298
Address: Xinle City east Industrial Park 12
Premium Coccidia Supplier from China – Custom Solutions & Factory Price

The coccidia market, underpinning global animal health, is undergoing a transformative phase driven by technological breakthroughs, evolving regulatory standards, and surging demands for custom animal treatment solutions. Especially in China, which has emerged as a leading coccidia producer and coccidia supplier, innovation in coccidia detection, prevention, and treatment are setting new benchmarks for the industry.

Shijiazhuang Huajun Animal Pharmaceutical Co., LTD stands at the forefront, offering not only advanced coccidia therapies but also custom manufacturing from our state-of-the-art coccidia factory. In this comprehensive resource, we analyze industry trends, key parameters, technical comparisons, and the real-world applications of products like Penicillin G Procaine and Dihydrostreptomycin Sulfate Injection 20/20, currently one of the most effective solutions for bacterial complications related to coccidia infections in livestock.

1. Understanding Coccidia and Its Global Impact

Coccidia refer to a group of apicomplexan protozoa parasites, notorious for causing coccidiosis in a wide range of livestock species including cattle, sheep, swine, goats, horses, as well as poultry. Severe infestation can lead to intestinal damage, weight loss, decreased productivity, and even death, necessitating effective management, prevention, and control strategies. The global market for coccidia control is estimated to reach USD 2.8 billion by 2027 (Barta, 2014, NCBI), representing a crucial segment of animal health.

  • Key segments: China coccidia, custom coccidia, export-oriented coccidia factory, global coccidia supplier.
  • Applications: Livestock, companion animal, and industrial farming sectors.
  • Emerging trends: Rapid diagnostics, next-gen pharmaceuticals, custom dosing protocols, multi-pathogen vaccination.

2. Coccidia Industry Trends: Focus on China and Customization

Driven by increased meat and dairy consumption, the demand for effective coccidia management solutions in China has surged in tandem with modern intensive farming practices. According to the China Animal Health Association, the nation has invested heavily in coccidia R&D, custom diagnostics, and manufacturing, becoming a pivotal coccidia supplier for Asia and beyond. Specific trends include:

  1. Customization: Bespoke coccidia solutions, including tailored formulations and delivery systems, catering to niche livestock requirements.
  2. Advanced Detection: PCR and molecular-based methods replacing classic microscopy for early, high-accuracy diagnostics.
  3. Regulatory Upgrades: Stricter MRL (Maximum Residue Limit) and GMP standards observed in leading coccidia factory facilities.
  4. Sustainable Practices: Focus on eco-friendly ingredients and reduced antibiotic dependency.
Comparison of coccidia–Related Technical Parameters
Parameter Standard Value/Range Trends (2021-2024)
Coccidia Detection Limit 100-500 oocysts/g Moving to ≤50 oocysts/g (PCR-based)
Drug Efficacy Rate 97–99% Stable; new drugs in development
Drug Residue (MRL) ≤ 0.01 mg/kg Increasingly strict control
Production Output 500 tons/year (China coccidia factory) Annual increase of 8–10%
Customization Rate > 60% custom bulk orders Rising demand for custom products
Export Volume 25,000 tons/year (China) Up 14% since 2022

3. Product Spotlight: Penicillin G Procaine and Dihydrostreptomycin Sulfate Injection 20/20

Among the leading products combating secondary bacterial infections in animals suffering from coccidia, Penicillin G Procaine and Dihydrostreptomycin Sulfate Injection 20/20 stands out with its dual-action formula, targeting a broad spectrum of pathogens:

  • Key indications: Arthritis, mastitis, gastrointestinal, respiratory, and urinary tract infections caused by penicillin and dihydrostreptomycin sensitive microorganisms.
  • Multi-species efficacy: Suitable for calves, cattle, horses, goats, sheep, and swine.
  • Target pathogens include: Campylobacter, Clostridium, Corynebacterium, E.coli, Erysipelothrix, Haemophilus, Klebsiella, Listeria, Pasteurella, Salmonella, Staphylococcus, and Streptococcus spp.

For more details, please visit the product page: https://www.zthjpharma.com/penicillin-g-procaine-and-dihydrostreptomycin-sulfate-injection-20-20.html

3.1 Key Technical Indicators

Penicillin G Procaine and Dihydrostreptomycin Sulfate Injection 20/20 - Main Technical Data
Specification Value
Active Ingredient Penicillin G Procaine 200,000 IU + Dihydrostreptomycin Sulfate 200 mg / ml
Formulation Suspension for injection
Indications Arthritis, mastitis, and specified infections
Recommended Dosage 1 ml / 20 kg body weight
Withdrawal Time (milk/meat) 5 days / 14 days
Packaging 100 ml vial

4. Application Scenarios of Coccidia Solutions

  1. Livestock farms: Routine prevention and therapy for coccidia in newborn calves, lambs, piglets, and poultry, including those in intensive and semi-intensive farms.
  2. Veterinary clinics and hospitals: Targeted treatment of acute and chronic cases, supported by molecular-level diagnostics.
  3. Feed manufacturers: Integration of coccidiostats and vaccine adjuvants distributed globally by China coccidia supplier brands.
  4. Integrated supply chains: Export-oriented coccidia factory setups for direct multinational supply and custom bulk orders.

5. EEAT: Why Choose Shijiazhuang Huajun Animal Pharmaceutical as Your Coccidia Supplier?

  • Expertise: More than two decades in veterinary pharmaceutical R&D, specialized in both generic and custom coccidia solutions for livestock.
  • Authoritativeness: National veterinary GMP manufacturing license, full export and national drug approval certificates, participation in international symposia (WVA).
  • Trustworthiness: Transparent track record, open product validation data, satisfied clients in over 60 countries. Company news and whitepapers are published routinely on authoritative journals such as Veterinary Parasitology (Elsevier).

6. Professional FAQ Section: Coccidia and Product Technicalities

Q1: What is the active ingredient composition of Penicillin G Procaine and Dihydrostreptomycin Sulfate Injection 20/20?
The product contains Penicillin G Procaine 200,000 IU and Dihydrostreptomycin Sulfate 200 mg per ml. These two ingredients act synergistically, making it effective against a broad bacterial spectrum, especially microorganisms related to coccidia-induced complications.
Q2: What storage conditions are required for coccidia pharmaceutical products?
Store at temperatures between 2–25°C, in a dry environment, away from direct sunlight. most coccidia solutions remain stable for 24–36 months under recommended GMP-compliant storage.
Q3: What regulatory standards do leading coccidia factories and suppliers in China follow?
Major coccidia factories in China adhere to National Veterinary GMP, EU GMP, and ISO 9001/14001 standards, ensuring residue, efficacy, and safety benchmarks.
(China Animal Health Association)
Q4: Can you elaborate on the withdrawal periods for food-producing animals after using this product?
The withdrawal period for milk is 5 days; for meat, 14 days post last administration. This minimizes drug residues in end-consumer products.
Q5: How can custom coccidia solutions be specified for different livestock?
Customization can target species-specific pathogens, optimized dosage forms (injection, oral, feed premix), and flexible concentration ratios to meet farm-level requirements.
Q6: What are the major pathogens, other than coccidia, targeted by this product?
It covers Campylobacter, Clostridium, Corynebacterium, E.coli, Erysipelothrix, Haemophilus, Klebsiella, Listeria, Pasteurella, Salmonella, Staphylococcus, and Streptococcus spp.
Q7: Is evidence-based data available supporting product efficacy?
Yes. Multi-year field trials and peer-reviewed publications detail product efficacy, e.g., https://pubmed.ncbi.nlm.nih.gov/31327891/

7. Future Outlook: Digitalization and Smart Manufacturing in Coccidia Factories

The global coccidia market is poised to leverage digital manufacturing (IoT, AI-driven QC) for higher productivity and compliance. Smart diagnostics and traceability platforms are set to transform supply chain transparency, giving stakeholders from farmers to multinational distributors confidence in drug quality and sourcing. Industry benchmarks, such as those from the World Organisation for Animal Health (WOAH), provide strategic direction in both export and domestic markets.

8. Conclusion: Building Trust Through Technology and Global Reach

In the evolving realm of coccidia management, a reliable, innovative supplier such as Shijiazhuang Huajun Animal Pharmaceutical Co., LTD offers more than just products – it stands as a trusted partner. By providing high-precision, custom-formulated therapies and complying with leading international standards, we ensure animal health, product safety, and business sustainability. To learn more about coccidia solutions, feel free to contact us for consultation and partnership.

References:

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Asset 3

Need Help?
Drop us a message using the form below.

azAzerbaijani